terameprocol has been researched along with Melanoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dorr, RT; Hajicek, N; Kalaitzis, JA; Lambert, JD; Meyers, RO; Pourpak, A | 1 |
| Dorr, RT; Lambert, JD; Meyers, RO; Timmermann, BN | 1 |
2 other study(ies) available for terameprocol and Melanoma
| Article | Year |
|---|---|
Synthesis, characterization, and anti-melanoma activity of tetra-O-substituted analogs of nordihydroguaiaretic acid.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Masoprocol; Melanoma; Mice; Xenograft Model Antitumor Assays | 2009 |
tetra-O-methylnordihydroguaiaretic acid inhibits melanoma in vivo.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Cell Cycle; Colonic Neoplasms; DNA Replication; Female; Intracellular Membranes; Kidney; Liver; Lung Neoplasms; Male; Masoprocol; Melanoma; Melanoma, Experimental; Membrane Potentials; Mice; Mice, Inbred C57BL; Mice, SCID; Mitochondria; Neoplasm Transplantation; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2001 |